Skip to main content

ADVERTISEMENT

hematological disorders

Interview
12/13/2016
JCP Editors
Patients with cancer are often forced to choose between seeking specialized medical treatment at facilities located a significant distance from their homes or accepting less rigorous care at local treatment centers....
Patients with cancer are often forced to choose between seeking specialized medical treatment at facilities located a significant distance from their homes or accepting less rigorous care at local treatment centers....
...
12/13/2016
Journal of Clinical Pathways
Conference Coverage
12/06/2016
JCP Editors
Founded in 1958, the American Society of Hematology (ASH) is considered the premier professional society for physicians and scientists specializing in benign and malignant blood disorders. The organization is...
Founded in 1958, the American Society of Hematology (ASH) is considered the premier professional society for physicians and scientists specializing in benign and malignant blood disorders. The organization is...
...
12/06/2016
Journal of Clinical Pathways
11/30/2016
JCP Editors
Many patients with hematologic cancers receiving highly emetic chemotherapy regimens do not achieve adequate control of chemotherapy-induced nausea and vomiting (CINV), according to study results presented at the...
Many patients with hematologic cancers receiving highly emetic chemotherapy regimens do not achieve adequate control of chemotherapy-induced nausea and vomiting (CINV), according to study results presented at the...
Many...
11/30/2016
Journal of Clinical Pathways
11/30/2016
JCP Editors
Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies, according to two studies presented at the 2016 ASH Annual Meeting and...
Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies, according to two studies presented at the 2016 ASH Annual Meeting and...
...
11/30/2016
Journal of Clinical Pathways
11/30/2016
JCP Editors
The implementation of a regret-based decision model may help patients with terminal blood cancers attain appropriate end-of-life care, according to research presented at the 2016 ASH Annual Meeting and...
The implementation of a regret-based decision model may help patients with terminal blood cancers attain appropriate end-of-life care, according to research presented at the 2016 ASH Annual Meeting and...
The...
11/30/2016
Journal of Clinical Pathways
11/30/2016
JCP Editors
In 2012, the American Board of Internal Medicine launched the Choosing Wisely campaign, which attempts to curb wasteful medical spending by limiting the use of unnecessary tests and procedures. Prominent medical...
In 2012, the American Board of Internal Medicine launched the Choosing Wisely campaign, which attempts to curb wasteful medical spending by limiting the use of unnecessary tests and procedures. Prominent medical...
In...
11/30/2016
Journal of Clinical Pathways
11/30/2016
JCP Editors
Inappropriate or unnecessary thrombophilia testing remains a frequent problem in the hospital inpatient setting, leading to significant financial ramifications and the potential for adverse medical care, according to...
Inappropriate or unnecessary thrombophilia testing remains a frequent problem in the hospital inpatient setting, leading to significant financial ramifications and the potential for adverse medical care, according to...
...
11/30/2016
Journal of Clinical Pathways
Research in Review
11/02/2016
JCP Editors
Patients with chronic myeloid leukemia (CML) and a history of prior malignancies appear to have the same outcomes as patients with no prior malignancies, according to a study published in Cancer. ------ Related...
Patients with chronic myeloid leukemia (CML) and a history of prior malignancies appear to have the same outcomes as patients with no prior malignancies, according to a study published in Cancer. ------ Related...
...
11/02/2016
Journal of Clinical Pathways